CTCE-0324

N/A

Report date: 2023/02/04 20:21:17

Base Information

Drug NameCTCE-0324
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionAngiogenesis inducersCXC chemokine receptor modulators
TargetsCXC chemokine receptor
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemokine Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemokine Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A